Verifying peptide purity & reading a Certificate of Analysis
A working guide for researchers, formulators, and QC scientists who need to know whether a peptide is actually what the label says it is — and what to look for on the Certificate of Analysis (CoA) that should accompany it.
Research-grade vs. certified peptides
"Research-grade" is a marketing term, not an analytical specification. It usually means the peptide was synthesized for laboratory use and ships with a manufacturer-stated purity — most often a single HPLC chromatogram and a mass spectrum from the production batch. Certified peptides, by contrast, have been independently verified by an analytical laboratory: identity, purity, content, and (where applicable) sterility and endotoxin are each measured against validated methods and released on a signed CoA.
The practical difference shows up in three places: dose-response reproducibility, impurity-driven artifacts in vivo, and the ability to defend your results in a regulatory filing or peer review. Purity peptide labs run the orthogonal tests that catch the failure modes a single supplier chromatogram can hide.
How HPLC purity analysis actually works
Reversed-phase HPLC (RP-HPLC) separates a peptide and its synthesis-related impurities on a C18 stationary phase using a water/acetonitrile gradient with 0.1% TFA. UV detection at 214 nm (peptide bond) and 280 nm (aromatic residues) produces a chromatogram in which each peak corresponds to a distinct species.
- Main peak %: area of the parent peptide divided by total integrated peak area, expressed as area %.
- Related impurities: deletion sequences, deamidation/oxidation products, scrambled disulfides, residual protecting groups, and synthesis byproducts that elute near the main peak.
- Method validation: a defensible purity number requires demonstrated specificity, linearity, repeatability, and a documented limit of detection — without it, the % area is just an estimate.
Apollo Analytical reports purity to a 0.1% impurity threshold using validated gradients tuned for the chemistry being tested, with orthogonal confirmation by a second column or buffer system when the impurity profile is ambiguous.
Identity confirmation by mass spectrometry
Purity tells you the peptide is clean. Mass spec tells you it's the right peptide. ESI-MS confirms the intact mass to within ±0.5 Da for most peptides under 10 kDa, and MS/MS sequencing fragments the peptide to verify the residue order — critical for catching transpositions, single-residue substitutions, and D/L isomers that HPLC cannot resolve.
How to read a Certificate of Analysis
A complete peptide CoA from a qualified laboratory contains, at minimum:
| Field | What to verify |
|---|---|
| Sample ID & lot # | Matches the vial label exactly. |
| Sequence (one-letter) | Matches your ordered sequence; modifications (Ac-, -NH2, PEG, biotin) are stated explicitly. |
| Theoretical MW | Calculated, not just measured — confirms the right chemistry was assumed. |
| Observed mass (ESI-MS) | Within ±0.5 Da of theoretical; charge states reported. |
| HPLC purity (% area) | Method, column, gradient, and detection wavelength are all listed. |
| Net peptide content | From AAA or nitrogen analysis — required for accurate dosing. |
| Counter-ion & water content | TFA, acetate, or HCl salt form; residual water by Karl Fischer. |
| Sterility / endotoxin | USP <71> and LAL only when the peptide is intended for injectable use. |
| Method & analyst signatures | Named scientist, date, and method reference — not a generic stamp. |
Red flags: a CoA with no method reference, a purity figure but no chromatogram, identity stated as "confirmed by MS" without an observed mass, or a single signature with no laboratory address. Any of these means you have a supplier spec sheet, not a verified Certificate of Analysis.
When to escalate to a purity peptide lab
Independent verification is worth the turnaround any time the downstream decision is expensive — IND-enabling studies, GLP toxicology, clinical manufacturing, structure–activity studies where impurity carryover would confound the readout, or any batch where the supplier CoA is incomplete. A qualified peptide testing lab can typically deliver a verified CoA in 5 business days or less for most tests from sample receipt.